SG151330A1 - Process for production of optically active amine derivatives - Google Patents

Process for production of optically active amine derivatives

Info

Publication number: SG151330A1
Authority: SG; Singapore
Prior art keywords: optically active; amine derivatives; active amine; production; indeno
Prior art date: 2004-09-13

Application number

SG200902222-9A

Other languages

English (en)

Inventor

Shinichi Urayama

Eigo Mutou

Atsushi Inagaki

Takashi Okada

Shigeharu Sugisaki

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-13

Filing date

2005-09-12

Publication date

2009-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36059992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG151330(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-09-12 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2009-04-30 Publication of SG151330A1 publication Critical patent/SG151330A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Reproductive Health (AREA)
Emergency Medicine (AREA)
Gynecology & Obstetrics (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Furan Compounds (AREA)

SG200902222-9A 2004-09-13 2005-09-12 Process for production of optically active amine derivatives SG151330A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2004265307		2004-09-13

Publications (1)

Publication Number	Publication Date
SG151330A1 true SG151330A1 (en)	2009-04-30

Family

ID=36059992

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG200902222-9A SG151330A1 (en)	2004-09-13	2005-09-12	Process for production of optically active amine derivatives

Country Status (32)

Country	Link
US (4)	US8097737B2 (fr)
EP (2)	EP1792899B1 (fr)
JP (2)	JP5127228B2 (fr)
KR (1)	KR101298335B1 (fr)
CN (2)	CN101056867B (fr)
AR (1)	AR050737A1 (fr)
AU (1)	AU2005283521B2 (fr)
BR (1)	BRPI0515170A (fr)
CA (2)	CA2579121C (fr)
CR (2)	CR8975A (fr)
EC (1)	ECSP077317A (fr)
ES (1)	ES2485890T3 (fr)
GE (1)	GEP20094725B (fr)
GT (2)	GT200500257AA (fr)
HN (1)	HN2005000548A (fr)
IL (2)	IL181462A (fr)
MA (1)	MA28855B1 (fr)
MX (1)	MX2007002822A (fr)
MY (2)	MY158073A (fr)
NO (1)	NO20071866L (fr)
NZ (1)	NZ553562A (fr)
PA (1)	PA8645701A1 (fr)
PE (3)	PE20081390A1 (fr)
PH (1)	PH12012501172A1 (fr)
RU (1)	RU2385318C2 (fr)
SA (1)	SA05260347A (fr)
SG (1)	SG151330A1 (fr)
TW (1)	TWI400220B (fr)
UA (1)	UA95598C2 (fr)
UY (1)	UY29118A1 (fr)
WO (1)	WO2006030739A1 (fr)
ZA (1)	ZA200701724B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5450056B2 (ja) *	2007-03-19	2014-03-26	武田薬品工業株式会社	アリルアミン不斉水素化法
WO2008150953A1 (fr) *	2007-05-30	2008-12-11	Dr. Reddy's Laboratories Ltd.	Procédé de préparation de rameltéon et substances apparentées
EP2069320A2 (fr)	2007-05-31	2009-06-17	Teva Pharmaceutical Industries Ltd.	Procédé de synthèse du rameltéon et ses intermédiaires
WO2009060318A2 (fr) *	2007-07-12	2009-05-14	Teva Pharmaceutical Industries Ltd.	Formes polymorphes de rameltéon et leurs procédés de préparation
CN101531647B (zh) *	2008-03-13	2012-10-31	常州亚邦制药有限公司	(±)-2-(1,6,7,8-四氢-2H-茚并[5,4-b]呋喃-8-基)乙胺的拆分方法
JP2011528012A (ja) *	2008-07-14	2011-11-10	レツク・フアーマシユーテイカルズ・デー・デー	ラメルテオンの調製における中間体としての６，７−ジヒドロ−１ｈ−インデノ［５，４−ｂ］フラン−８（２ｈ）−オンの合成
US20100152468A1 (en) *	2008-10-16	2010-06-17	Teva Pharmaceutical Industries Ltd.	Process for the synthesis of ramelteon and its intermediates
EP2396309A1 (fr)	2009-02-12	2011-12-21	LEK Pharmaceuticals d.d.	Synthèse de (s)-n-ý2-(1,6,7,8-tétrahydro-2h-indéno-ý5,4-b¨furan-8-yl)éthyl¨propionamide
CN101824012B (zh) *	2009-03-02	2011-12-07	四川大学	2-(1,6,7,8-四氢-2H-茚并-[5,4-b]呋喃-8-基)乙腈及其制备方法和用途
EP2406242B1 (fr)	2009-03-10	2013-06-05	Industriale Chimica S.R.L.	Procédé de préparation du rameltéon
EP2243775A1 (fr)	2009-04-07	2010-10-27	LEK Pharmaceuticals d.d.	Synthèse de 1-(2,3-dihydrobenzofuran-4-YL)éthanone en tant qu'intermédiaire dans la préparation de rameltéon
WO2011027323A1 (fr)	2009-09-03	2011-03-10	Ranbaxy Laboratories Limited	Procédé de préparation de ramelteon
WO2011027319A1 (fr)	2009-09-03	2011-03-10	Ranbaxy Laboratories Limited	Procédé de préparation d'un produit intermédiaire de rameltéon
CN101665477B (zh) *	2009-09-21	2012-05-09	四川大学	(e)-3-(苯并呋喃-5-基)丙烯酸酯类化合物、其制备方法和用途
CN101648931B (zh) *	2009-09-21	2012-05-09	四川大学	一种3-(2,3-二氢苯并呋喃-5-基)-丙酸的制备方法
EP2483258A1 (fr)	2009-09-29	2012-08-08	Lonza Ltd.	Procédé de préparation de 1,2,6,7-tétrahydro-8h-indeno[5,4-b]furan-8-one
WO2012035303A2 (fr)	2010-09-17	2012-03-22	Cipla Limited Et Al	Nouveau procédé de synthèse du ramelteon et intermédiaires clés pour la synthèse du ramelteon
CN103664849B (zh) *	2012-08-31	2017-03-29	上海阳帆医药科技有限公司	制备2‑(1,6,7,8‑四氢‑2H‑茚并[5,4‑b]呋喃‑8‑亚基乙胺的方法
CN102924410A (zh) *	2012-10-29	2013-02-13	华润赛科药业有限责任公司	一种雷美替胺的制备方法及其中间体
CN103396387A (zh) *	2013-08-07	2013-11-20	安徽联创药物化学有限公司	雷美替胺中间体的制备方法
CN105277628B (zh) *	2014-07-07	2017-05-31	南京长澳医药科技有限公司	通过高效液相色谱法分离测定雷美替胺及其杂质的方法
CN104402848B (zh) *	2014-09-22	2017-02-08	珠海联邦制药股份有限公司	雷美替胺中的杂质化合物的制备方法及制备的标准品
CN105622557B (zh) *	2014-11-05	2018-12-04	上海医药工业研究院	雷美替胺中间体及其制备方法
KR102359229B1 (ko)	2020-04-16	2022-02-07	제이투에이치바이오텍 (주)	라멜테온의 제조 방법 및 이러한 제조 방법에 이용되는 중간체 화합물
CN115477628A (zh) *	2022-10-17	2022-12-16	江苏海悦康医药科技有限公司	一种雷美替胺二聚体的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0757758B2 (ja)	1988-10-24	1995-06-21	高砂香料工業株式会社	ルテニウム―ホスフィン錯体
US6060503A (en)	1991-12-02	2000-05-09	Endorecherche, Inc.	Benzopyran-containing compounds and method for their use
WO1996026931A1 (fr)	1995-03-02	1996-09-06	Sankyo Company, Limited	Derives de thiazolidinone optiquement actifs
EP1199304A1 (fr) *	1997-03-05	2002-04-24	Takeda Chemical Industries, Ltd.	Composés bicycliques et composition pharmaceutique contenant un composé tricyclique pour le traitement ou la prévention de troubles de sommeil
US6034239A (en) *	1996-03-08	2000-03-07	Takeda Chemical Industries, Ltd.	Tricyclic compounds, their production and use
EP0885210B2 (fr) *	1996-03-08	2008-06-18	Takeda Pharmaceutical Company Limited	Composés tricycliques avec une affinité de liaison pour des recepteurs de la melatonine, leur production et leur utilisation
JP2884153B2 (ja) *	1996-03-08	1999-04-19	武田薬品工業株式会社	三環性化合物、その製造法および剤
JP4242940B2 (ja)	1997-02-13	2009-03-25	高砂香料工業株式会社	光学活性アミン誘導体の製造法
JP4081161B2 (ja) *	1997-09-05	2008-04-23	武田薬品工業株式会社	光学活性化合物の製造法
JP3509637B2 (ja) *	1998-06-09	2004-03-22	武田薬品工業株式会社	睡眠障害予防治療剤
CN1206996C (zh) *	1998-06-09	2005-06-22	武田药品工业株式会社	用于治疗或预防睡眠障碍的药物组合物
CA2650698C (fr)	2000-11-17	2013-05-28	Takeda Pharmaceutical Company Limited	Preparation pharmaceutique contenant de la copolyvidone
JP3633895B2 (ja) *	2000-11-17	2005-03-30	武田薬品工業株式会社	コポリビドン含有製剤

2005
- 2005-09-06 TW TW094130493A patent/TWI400220B/zh not_active IP Right Cessation
- 2005-09-09 PE PE2008001369A patent/PE20081390A1/es not_active Application Discontinuation
- 2005-09-09 PE PE2005001052A patent/PE20060662A1/es not_active Application Discontinuation
- 2005-09-09 PE PE2012001990A patent/PE20130154A1/es not_active Application Discontinuation
- 2005-09-12 EP EP05782085.4A patent/EP1792899B1/fr not_active Expired - Lifetime
- 2005-09-12 ES ES05782085.4T patent/ES2485890T3/es not_active Expired - Lifetime
- 2005-09-12 PH PH1/2012/501172A patent/PH12012501172A1/en unknown
- 2005-09-12 UA UAA200702582A patent/UA95598C2/ru unknown
- 2005-09-12 AR ARP050103792A patent/AR050737A1/es not_active Application Discontinuation
- 2005-09-12 SG SG200902222-9A patent/SG151330A1/en unknown
- 2005-09-12 BR BRPI0515170-8A patent/BRPI0515170A/pt not_active IP Right Cessation
- 2005-09-12 ZA ZA200701724A patent/ZA200701724B/xx unknown
- 2005-09-12 GE GEAP20059926A patent/GEP20094725B/en unknown
- 2005-09-12 JP JP2006535875A patent/JP5127228B2/ja not_active Expired - Lifetime
- 2005-09-12 NZ NZ553562A patent/NZ553562A/en not_active IP Right Cessation
- 2005-09-12 MY MYPI20091231A patent/MY158073A/en unknown
- 2005-09-12 US US11/662,684 patent/US8097737B2/en active Active
- 2005-09-12 WO PCT/JP2005/016761 patent/WO2006030739A1/fr not_active Ceased
- 2005-09-12 MY MYPI20054286A patent/MY147822A/en unknown
- 2005-09-12 CN CN2005800388478A patent/CN101056867B/zh not_active Expired - Lifetime
- 2005-09-12 CA CA2579121A patent/CA2579121C/fr not_active Expired - Lifetime
- 2005-09-12 RU RU2007113811/04A patent/RU2385318C2/ru not_active IP Right Cessation
- 2005-09-12 CA CA2764314A patent/CA2764314C/fr not_active Expired - Lifetime
- 2005-09-12 EP EP12182935A patent/EP2537842A1/fr not_active Withdrawn
- 2005-09-12 KR KR1020077005754A patent/KR101298335B1/ko not_active Expired - Fee Related
- 2005-09-12 MX MX2007002822A patent/MX2007002822A/es active IP Right Grant
- 2005-09-12 AU AU2005283521A patent/AU2005283521B2/en not_active Ceased
- 2005-09-12 CN CN201110304598XA patent/CN102516211A/zh active Pending
- 2005-09-13 HN HN2005000548A patent/HN2005000548A/es unknown
- 2005-09-13 GT GT200500257AK patent/GT200500257AA/es unknown
- 2005-09-13 PA PA20058645701A patent/PA8645701A1/es unknown
- 2005-09-13 UY UY29118A patent/UY29118A1/es not_active Application Discontinuation
- 2005-09-13 GT GT200500257A patent/GT200500257A/es unknown
- 2005-11-08 SA SA05260347A patent/SA05260347A/ar unknown
2007
- 2007-02-20 IL IL181462A patent/IL181462A/en not_active IP Right Cessation
- 2007-03-06 CR CR8975A patent/CR8975A/es unknown
- 2007-03-09 MA MA29745A patent/MA28855B1/fr unknown
- 2007-03-13 EC EC2007007317A patent/ECSP077317A/es unknown
- 2007-04-12 NO NO20071866A patent/NO20071866L/no not_active Application Discontinuation
2010
- 2010-08-09 IL IL207510A patent/IL207510A/en not_active IP Right Cessation
2011
- 2011-12-14 US US13/325,946 patent/US20120088826A1/en not_active Abandoned
- 2011-12-21 CR CR20110698A patent/CR20110698A/es unknown
2012
- 2012-01-26 JP JP2012014435A patent/JP5615304B2/ja not_active Expired - Lifetime
- 2012-08-29 US US13/597,361 patent/US8609871B2/en not_active Expired - Lifetime
2013
- 2013-11-13 US US14/079,607 patent/US20140066499A1/en not_active Abandoned

Also Published As

Publication number	Publication date
IL181462A0 (en)	2007-07-04
EP1792899A4 (fr)	2009-12-16
PA8645701A1 (es)	2006-09-22
CN102516211A (zh)	2012-06-27
NO20071866L (no)	2007-05-29
EP1792899A1 (fr)	2007-06-06
KR101298335B1 (ko)	2013-08-20
IL181462A (en)	2011-12-29
RU2385318C2 (ru)	2010-03-27
US20090036521A1 (en)	2009-02-05
AU2005283521A1 (en)	2006-03-23
US8609871B2 (en)	2013-12-17
GT200500257A (es)	2006-04-17
CN101056867B (zh)	2011-12-07
TW200613239A (en)	2006-05-01
PE20060662A1 (es)	2006-08-22
HN2005000548A (es)	2007-04-20
UY29118A1 (es)	2006-06-30
US8097737B2 (en)	2012-01-17
IL207510A (en)	2013-02-28
PH12012501172A1 (en)	2014-04-28
CA2764314A1 (fr)	2006-03-23
CN101056867A (zh)	2007-10-17
GEP20094725B (en)	2009-07-10
UA95598C2 (ru)	2011-08-25
SA05260347A (ar)	2005-12-03
PE20130154A1 (es)	2013-02-27
TWI400220B (zh)	2013-07-01
NZ553562A (en)	2010-08-27
PE20081390A1 (es)	2008-10-24
MA28855B1 (fr)	2007-09-03
MX2007002822A (es)	2007-04-23
CR8975A (es)	2007-08-28
ECSP077317A (es)	2007-04-26
KR20070054200A (ko)	2007-05-28
ZA200701724B (en)	2008-08-27
CA2579121C (fr)	2013-07-30
RU2007113811A (ru)	2008-10-20
BRPI0515170A (pt)	2008-07-08
GT200500257AA (es)	2008-07-28
MY147822A (en)	2013-01-31
CA2764314C (fr)	2014-06-17
MY158073A (en)	2016-08-30
JP2012116848A (ja)	2012-06-21
US20120088826A1 (en)	2012-04-12
AR050737A1 (es)	2006-11-15
EP2537842A1 (fr)	2012-12-26
JP5127228B2 (ja)	2013-01-23
US20130079397A1 (en)	2013-03-28
WO2006030739A1 (fr)	2006-03-23
JPWO2006030739A1 (ja)	2008-05-15
JP5615304B2 (ja)	2014-10-29
AU2005283521B2 (en)	2011-10-13
EP1792899B1 (fr)	2014-07-09
CA2579121A1 (fr)	2006-03-23
US20140066499A1 (en)	2014-03-06
ES2485890T3 (es)	2014-08-14
CR20110698A (es)	2012-03-08

Publication	Publication Date	Title
SG151330A1 (en)	2009-04-30	Process for production of optically active amine derivatives
PL392725A1 (pl)	2010-12-06	Nowe związki pośrednie do syntezy związków triazolopirymidyny oraz sposób ich wytwarzania
WO2009102155A3 (fr)	2009-11-12	Processus de préparation de dérivés d'acide 2-méthyl-2´-phénylpropionique et nouveaux composés intermédiaires
WO2008108998A3 (fr)	2008-11-20	Procédé pour augmenter le rendement et améliorer la purification de produits provenant de réactions avec une transaminase
AU2002345388A1 (en)	2003-03-03	New chiral salen catalyst and methods for the preparation of chiral compounds from racemic epoxides by using new catalyst
WO2005048954A3 (fr)	2006-07-27	Procede continu de production d'hydroxyazapirones par oxydation
EP1460065A4 (fr)	2005-04-20	Procedes pour produire des composes de diamine cyclique ou des sels de ceux-ci
ATE509117T1 (de)	2011-05-15	Herstellungsverfahren für hyaluronsäure oder ihre derivate
WO2005063731A3 (fr)	2005-11-17	Production de dihydronepetalactone par reduction de l'acide nepetalique
EP1572657A4 (fr)	2006-03-01	Procede de preparation de derives de quinolonecarboxylate
GEP20074025B (en)	2007-01-25	Process for preparing acid salts of gemifloxacin
TW200740730A (en)	2007-11-01	Process for producing ethylenedlamine derivatives having halogenated-carbamate group and acyl group, and intermediates thereof
PT1169297E (pt)	2005-02-28	Processo para a producao de serinol
UA89037C2 (ru)	2009-12-25	Способ получения кислотно-аддитивной соли венлафаксина
HU0402634D0 (en)	2005-02-28	Process for producing meloxicam and meloxicam potassium salt of high purity
WO2007010412A3 (fr)	2007-08-30	Syntheses et preparations de narwedine et de nouveaux composes associes
BG108151A (en)	2004-09-30	Caloporoside derivatives, methods for the production thereof and their use
DE602006016651D1 (de)	2010-10-14	Zwischenprodukte und verfahren zur herstellung aromatischer derivate von 1-adamantan
UA84150C2 (ru)	2008-09-25	Йодопиразолилкарбоксанилиды, способ их получения, производные йодопиразолилкарбоновой кислоты и средство для борьбы с нежелательными микроорганизмами
UA69783A (en)	2004-09-15	A method for the preparation of solid caustic soda and an apparatus for realizing the same
TH81175A (th)	2006-11-16	กระบวนการสำหรับการผลิตอนุพันธ์แอมีนทำปฏิกิริยาเชิงแสง
MXPA04004537A (es)	2004-08-11	Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos.
TH81175B (th)	2006-11-16	กระบวนการสำหรับการผลิตอนุพันธ์แอมีนทำปฏิกิริยาเชิงแสง
WO2003029246A1 (fr)	2003-04-10	Procede de production de derive d'acetamide pyrimidone et des cristaux de celui-ci
CA2438891A1 (fr)	2002-09-06	Procede de preparation de dihydropyrones optiquement actives